UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
VTYX holding history
Ventyx Biosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTYX overviewAll 13F holders of VTYXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −68,216−100.0% | Sold out | Holders |
| Q4 2025 | 68,216 | $616.0K | <0.1% | −459,076−87.1% | Reduced | Holders |
| Q3 2025 | 527,292 | $1.64M | <0.1% | +159,783+43.5% | Added | Holders |
| Q2 2025 | 367,509 | $786.5K | <0.1% | +57,897+18.7% | Added | Holders |
| Q1 2025 | 309,612 | $356.1K | <0.1% | −3,472,971−91.8% | Reduced | Holders |
| Q4 2024 | 3,782,583 | $8.28M | <0.1% | +2,585,197+215.9% | Added | Holders |
| Q3 2024 | 1,197,386 | $2.61M | <0.1% | +1,175,766+5,438.3% | Added | Holders |
| Q2 2024 | 21,620 | $49.9K | <0.1% | −37,899−63.7% | Reduced | Holders |
| Q1 2024 | 59,519 | $327.4K | <0.1% | +59,519 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −193−100.0% | Sold out | Holders |
| Q3 2023 | 193 | $6.70K | <0.1% | −42,437−99.5% | Reduced | Holders |
| Q2 2023 | 42,630 | $1.40M | <0.1% | +42,346+14,910.6% | Added | Holders |
| Q1 2023 | 284 | $9.52K | <0.1% | −945−76.9% | Reduced | Holders |
| Q4 2022 | 1,229 | $40.3K | <0.1% | +1,229 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −2,052−100.0% | Sold out | Holders |
| Q2 2022 | 2,052 | $25.0K | <0.1% | −816−28.5% | Reduced | Holders |
| Q1 2022 | 2,868 | $39.0K | <0.1% | −932−24.5% | Reduced | Holders |
| Q4 2021 | 3,800 | $76.0K | <0.1% | +3,800 | New | Holders |